showed a trendP = . 060
Patients who underwent BrM-directed therapy showed a trend toward longer survival from BrM diagnosis when compared with patients receiving supportive care only (median OS, 6.5 vs 0.8 months, P = . 060).
Patients who underwent BrM-directed therapy showed a trend toward longer survival from BrM diagnosis when compared with patients receiving supportive care only (median OS, 6.5 vs 0.8 months, P = . 060).